Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Deferred Taxes (2021 - 2025)

Collegium Pharmaceutical has reported Deferred Taxes over the past 5 years, most recently at -$10.1 million for Q4 2025.

  • Quarterly results put Deferred Taxes at -$10.1 million for Q4 2025, up 0.83% from a year ago — trailing twelve months through Dec 2025 was -$25.7 million (up 4.31% YoY), and the annual figure for FY2025 was -$25.7 million, up 4.31%.
  • Deferred Taxes for Q4 2025 was -$10.1 million at Collegium Pharmaceutical, up from -$12.1 million in the prior quarter.
  • Over the last five years, Deferred Taxes for COLL hit a ceiling of $2.1 million in Q3 2022 and a floor of -$62.6 million in Q2 2021.
  • Median Deferred Taxes over the past 5 years was -$3.4 million (2022), compared with a mean of -$7.4 million.
  • Biggest five-year swings in Deferred Taxes: skyrocketed 656.23% in 2022 and later crashed 9491.3% in 2024.
  • Collegium Pharmaceutical's Deferred Taxes stood at -$15.0 million in 2021, then surged by 92.82% to -$1.1 million in 2022, then soared by 68.65% to -$338000.0 in 2023, then plummeted by 2904.73% to -$10.2 million in 2024, then increased by 0.83% to -$10.1 million in 2025.
  • The last three reported values for Deferred Taxes were -$10.1 million (Q4 2025), -$12.1 million (Q3 2025), and -$2.9 million (Q2 2025) per Business Quant data.